Stockscreener 앱 받기
1.221
3.10%
-0.039
시간 외 거래:
1.22
-0.001
-0.08%
Bionexus Gene Lab Corp (BGLC) 재무 분석
손익 계산서
분기별
*모든 숫자는 백만 단위입니다.
| 기간 종료일 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| 기간 | 3개월 | 3개월 | 3개월 | 3개월 | 3개월 |
| Revenues |
233.40%
0.0762
|
0.0228 | 0.4838 | 2.5438 | 2.2603 |
| Cost Of Revenue |
167.32%
0.0632
|
0.0236 | 0.4877 | 2.1661 | 1.8922 |
| Gross Profit |
1,743%
0.013
|
-0.00079 | -0.00398 | 0.3777 | 0.368 |
| Operating Expenses |
30.30%
0.4164
|
0.5974 | 1.0523 | 1.188 | 1.1888 |
| Operating Income/Loss |
47.75%
-0.2824
|
-0.5405 | -1.0328 | -0.7025 | -0.6113 |
| Income/Loss From Continuing Operations Before Tax |
47.30%
-0.2865
|
-0.5436 | -1.0361 | -0.709 | -0.6162 |
| Income Tax Expense/Benefit, Current |
-
|
- | - | - | - |
| Income Tax Expense/Benefit, Deferred |
-
|
- | - | - | - |
| Income Tax Expense/Benefit |
-
|
- | - | - | - |
| Net Income/Loss |
47.30%
-0.2865
|
-0.5436 | -1.0361 | -0.709 | -0.6162 |
| Diluted Average Shares |
0.00%
2.4173
|
2.4173 | - | 1.7966 | 1.7966 |
| Diluted Earnings Per Share |
47.56%
-0.118
|
-0.225 | - | -0.395 | -0.343 |
9.25%
1.09%
자본화:
|
볼륨(24시간):